Search in:

The World Journal of Biological Psychiatry Volume 15, 2014 - Issue 3

Submit an article Journal homepage

818

Views

CrossRef citations to date

Altmetric

Research Article

Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial

Joachim CordesDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Duesseldorf, GermanyCorrespondence[email protected]

Johanna ThünkerDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Duesseldorf, Germany

Gunnar RegenbrechtDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Duesseldorf, Germany

Jürgen ZielasekDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Duesseldorf, Germany

Christoph U. CorrellThe Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY, USA;Albert Einstein College of Medicine, Bronx, NY, USA

Christian Schmidt-KraepelinDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Duesseldorf, Germany

Christian Lange-AsschenfeldtDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Duesseldorf, Germany

Marcus W. AgelinkDepartment of Psychiatry, Psychotherapy and Preventive Medicine, Ruhr University Bochum, Bochum, Germany

Kai G. KahlDepartment of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Germany

Wolfgang GaebelDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University Duesseldorf, Germany

Ansgar KlimkeClinic for Psychiatry and Psychotherapy, Klinikum Offenbach GmbH, Offenbach, Germany

Hans HaunerElse Kröner-Fresenius Center for Nutritional Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany

show all

Pages 229-241 | Received 17 Nov 2010, Accepted 26 May 2011, Published online: 11 Jul 2011

Cite this article
https://doi.org/10.3109/15622975.2011.592546
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (16)

Anna Maria Peisser, Sebastian Cornet, Sabrina Moerkl & Annabel Müller-Stierlin. (2023) „Aber ohne therapeutische Begleitung, schaffe ich es nicht“ – Exploration von Erfahrungen von Menschen mit psychischen Erkrankungen hinsichtlich der Unterstützung bei ernährungsbezogenen Problemen. Psychiatrische Praxis.
Crossref

Tetyana Rocks, Scott B Teasdale, Caitlin Fehily, Claire Young, Gina Howland, Blair Kelly, Samantha Dawson, Felice Jacka, James A Dunbar & Adrienne O’Neil. (2022) Effectiveness of nutrition and dietary interventions for people with serious mental illness: systematic review and meta‐analysis. Medical Journal of Australia 217:S7.
Crossref

Nick Meader, Hollie Melton, Connor Evans, Kath Wright, David Shiers, Elena Ratschen, Sofia Dias, Ceri Dare, Gordon Johnston, Harminder Kaur, Michel Syrett, Christopher J Armitage, Rachel Churchill, Simon Gilbody & Peter Coventry. (2022) Multiple versus single risk behaviour interventions for people with severe mental illness: a network meta-analysis and qualitative synthesis. Health and Social Care Delivery Research 10:6, pages 1-186.
Crossref

Charlotte Lee, Carmen Piernas, Cristina Stewart, Moscho Michalopoulou, Anisa Hajzadeh, Rhiannon Edwards, Paul Aveyard & Felicity Waite. (2021) Identifying effective characteristics of behavioral weight management interventions for people with serious mental illness: A systematic review with a qualitative comparative analysis. Obesity Reviews 23:1.
Crossref

Blanca Fernández-Abascal, Paula Suárez-Pinilla, Carlos Cobo-Corrales, Benedicto Crespo-Facorro & Marta Suárez-Pinilla. (2021) In- and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised controlled trials in patients with schizophrenia spectrum disorders and first episode of psychosis. Neuroscience & Biobehavioral Reviews 125, pages 535-568.
Crossref

Adriana Cimo, Desmond Loong & Carolyn S. Dewa. (2020) Exploring the Outcomes of a Pilot Education Program Tailored for Adults With Type 2 Diabetes and Mental Illness in a Community Mental Health Care Setting. Canadian Journal of Diabetes 44:6, pages 461-472.e1.
Crossref

Helene Speyer, Ane Storch Jakobsen, Casper Westergaard, Hans Christian Brix Nørgaard, Charlotta Pisinger, Jesper Krogh, Carsten Hjorthøj, Merete Nordentoft, Christian Gluud, Christoph U. Correll & Kirstine Bro Jørgensen. (2019) Lifestyle Interventions for Weight Management in People with Serious Mental Illness: A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects. Psychotherapy and Psychosomatics 88:6, pages 350-362.
Crossref

Johanna Taylor, Jan R. Böhnke, Judy Wright, Ian Kellar, Sarah L. Alderson, Tom Hughes, Richard I. G. Holt & Najma Siddiqi. (2017) A core outcome set for evaluating self-management interventions in people with comorbid diabetes and severe mental illness: study protocol for a modified Delphi study and systematic review. Trials 18:1.
Crossref

Simon S Evers, Gretha J Boersma, Kellie LK Tamashiro, Anton JW Scheurink & Gertjan van Dijk. (2017) Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression. Journal of Psychopharmacology 31:11, pages 1437-1452.
Crossref

Britta Stapel, Alexandra Kotsiari, Michaela Scherr, Denise Hilfiker-Kleiner, Stefan Bleich, Helge Frieling & Kai G. Kahl. (2017) Olanzapine and aripiprazole differentially affect glucose uptake and energy metabolism in human mononuclear blood cells. Journal of Psychiatric Research 88, pages 18-27.
Crossref

Scott B. Teasdale, Philip B. Ward, Simon Rosenbaum, Katherine Samaras & Brendon Stubbs. (2018) Solving a weighty problem: Systematic review and meta-analysis of nutrition interventions in severe mental illness. British Journal of Psychiatry 210:2, pages 110-118.
Crossref

Johanna Taylor, Brendon Stubbs, Catherine Hewitt, Ramzi A. Ajjan, Sarah L. Alderson, Simon Gilbody, Richard I. G. Holt, Prakash Hosali, Tom Hughes, Tarron Kayalackakom, Ian Kellar, Helen Lewis, Neda Mahmoodi, Kirstine McDermid, Robert D. Smith, Judy M. Wright & Najma Siddiqi. (2017) The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis. PLOS ONE 12:1, pages e0168549.
Crossref

Holland C. DetkeMelissa P. DelBelloJohn LandryVicki Poole HoffmannAlexandra HeinlothRalf W. Dittmann. (2016) A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder. Journal of Child and Adolescent Psychopharmacology 26:10, pages 922-934.
Crossref

Helene Speyer, Hans Christian Brix Nørgaard, Merete Birk, Mette Karlsen, Ane Storch Jakobsen, Kamilla Pedersen, Carsten Hjorthøj, Charlotta Pisinger, Christian Gluud, Ole Mors, Jesper Krogh & Merete Nordentoft. (2016) The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity. World Psychiatry 15:2, pages 155-165.
Crossref

Emma E. McGinty, Julia Baller, Susan T. Azrin, Denise Juliano-Bult & Gail L. Daumit. (2015) Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review. Schizophrenia Bulletin, pages sbv101.
Crossref

P. Chue & G. Baker. 2015. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 63 83 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial

Articles from other publishers (16)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial

Citations (16)

Articles from other publishers (16)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date